{
    "organizations": [],
    "uuid": "79af26dd26a2585bb08e3734ee639370c34f6287",
    "author": "",
    "url": "https://www.reuters.com/article/brief-advanced-accelerator-applications/brief-advanced-accelerator-applications-enters-into-worldwide-license-agreement-with-cancer-targeted-technology-idUSFWN1Q20SK",
    "ord_in_thread": 0,
    "title": "BRIEF-Advanced Accelerator Applications Enters Into Worldwide License Agreement With Cancer Targeted Technology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 12, 2018 / 12:11 PM / in 10 minutes BRIEF-Advanced Accelerator Applications Enters Into Worldwide License Agreement With Cancer Targeted Technology Reuters Staff \nFeb 12 (Reuters) - Advanced Accelerator Applications SA : \n* ADVANCED ACCELERATOR APPLICATIONS SA - ENTERED INTO EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH CANCER TARGETED TECHNOLOGY \n* ADVANCED ACCELERATOR APPLICATIONS SA - AGREEMENT WITH CTT TO DEVELOP AND MARKET INVESTIGATIONAL NEW DRUG PRODUCT, F-18-LABELED CTT1057 \n* ADVANCED ACCELERATOR APPLICATIONS SA - TERMS OF AGREEMENT WITH CTT INCLUDE AN UPFRONT LICENSING FEE, CERTAIN MILESTONE AND ROYALTY PAYMENTS Source text for Eikon: Further company coverage:",
    "published": "2018-02-12T14:08:00.000+02:00",
    "crawled": "2018-02-12T14:24:39.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "accelerator",
        "application",
        "enters",
        "worldwide",
        "license",
        "agreement",
        "cancer",
        "targeted",
        "technology",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "advanced",
        "accelerator",
        "application",
        "sa",
        "advanced",
        "accelerator",
        "application",
        "sa",
        "entered",
        "exclusive",
        "worldwide",
        "license",
        "agreement",
        "cancer",
        "targeted",
        "technology",
        "advanced",
        "accelerator",
        "application",
        "sa",
        "agreement",
        "ctt",
        "develop",
        "market",
        "investigational",
        "new",
        "drug",
        "product",
        "ctt1057",
        "advanced",
        "accelerator",
        "application",
        "sa",
        "term",
        "agreement",
        "ctt",
        "include",
        "upfront",
        "licensing",
        "fee",
        "certain",
        "milestone",
        "royalty",
        "payment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}